欧洲药品开发市场发展生物资讯科学的机会

Abstract

This Frost & Sullivan research service titled Opportunities for Bioinformatics in European Drug Discovery Market provides a detailed analysis of the key factors driving growth in the European bioinformatics industry in the drug discovery market. The study also covers the basic aspects of bioinformatics including the segmentation pattern and the challenges faced by market participants.

Table of Contents

1. Executive Summary

• 1. Summary of Findings
  • 1. Summary

2. Glossary

• 1. Glossary of Terms
  • 1. Glossary

3. Research Methodology

• 1. Methodology Adopted
  • 1. Methodology

4. Overview of Challenges Faced by the Bioinformatics Industry

• 1. Challenges Faced by the Bioinformatics Industry
  • 1. Challenges

5. European Bioinformatics Market

• 1. Market Overview
  • 1. Overview
• 2. Segmentation
  • 1. Market Segment
• 3. Market Drivers
  • 1. Drivers
    • a. Increasing Demand for Advanced Data Handling Tools
    • b. Need to Develop Tools to Increase Drug Research Productivity
    • c. Increasing R&D Spend of the Government
    • d. Increasing Trend towards Dry Lab Techniques
    • e. Increasing Use of High Throughput Systems
    • f. Need to Eliminate False Leads and Cut Costs
• 4. Market Restraints
  • 1. Restraints
    • a. Pharmaceutical Research Gradually Relocating from Europe
    • b. European Companies' Conservative Attitude towards New Technologies
    • c. Proprietary and Incompatible Data Formats
    • d. Saturated Large Pharma Market
    • e. Attitude of Limited IT Spending
• 5. Revenue Forecasts
  • 1. Revenue Forecasts
• 6. Geographical Trends
  • 1. Geographic Trends
• 7. Competitive Analysis
  • 1. Competitive Structure
• 8. Company Profiling
  • 1. Company Profiles

6. Genomic Market

• 1. Genomic Market in Europe
  • 1. Introduction
  • 2. Market Engineering Measurements
  • 3. Revenue Forecasts

7. Proteomics Market

• 1. Proteomics Market in Europe
  • 1. Introduction
  • 2. Market Engineering Measurements
  • 3. Revenue Forecasts

8. Information Manipulation Market

• 1. Information Manipulation Market in Europe
  • 1. Introduction
  • 2. Market Engineering Measurements
  • 3. Revenue Forecasts

9. Geographic Trends

• 1. European Bioinformatics Market
  • 1. Overview
• 2. UK Bioinformatics Market
  • 1. Overview
  • 2. Market Engineering Measurements
  • 3. Revenue Forecasts
• 3. German Bioinformatics Market
  • 1. Overview
  • 2. Market Engineering Measurements
  • 3. Revenue Forecasts
• 4. French Bioinformatics Market
  • 1. Overview
  • 2. Market Engineering Measurements
  • 3. Revenue Forecasts
• 5. Scandinavian Bioinformatics Market
  • 1. Overview
  • 2. Market Engineering Measurements
  • 3. Revenue Forecasts
• 6. Benelux Bioinformatics Market
  • 1. Overview
  • 2. Market Engineering Measurements
  • 3. Revenue Forecasts

10. Strategic Recommendations

• 1. Recommendations
  • 1. Strategies

11. Database of Key Industry Participants

• 1. Key Industry Participants
  • 1. Database of Key Industry Participants

12. Appendix

• 1. Decision Support Database
  • 1. Decision Support Database

• Opportunities for Bioinformatics in European Drug Discovery Market: Market Challenges Ranked in Order of Impact (Europe), 2006-2013

• Traditional Method of Drug Discovery
• Modern Method of Drug discovery
• Market Segmentation of European Bioinformatics Market
• Opportunities for Bioinformatics in European drug Discovery Market: Market Drivers Ranked in Order of Impact (Europe), 2006-2013
• Opportunities for Bioinformatics in European Drug Discovery Market: Market Restraints Ranked in Order of Impact (Europe), 2006-2013
• Opportunities for Bioinformatics in European Drug Discovery Market: Revenue Forecasts (Europe), 2006-2013
• Opportunities for Bioinformatics in European drug Discovery Market: Competitive Structure (Region), 2006

• Opportunities for Bioinformatics in European Drug Discovery Market: Revenue Forecasts for Genomic Segment (Europe), 2006-2013

• Opportunities for Bioinformatics in European Drug Discovery Market: Revenue Forecasts for Proteomic Segment (Europe), 2006-2013

• Opportunities for Bioinformatics in European Drug Discovery Market: Revenue Forecasts for Information Manipulation Segment (Europe), 2006-2013

• Opportunities for Bioinformatics in European Drug Discovery market: Revenue Forecasts (United Kingdom), 2006-2013
• Opportunities for Bioinformatics in European Drug Discovery market: Revenue Forecasts (Germany), 2006-2013
• Opportunities for Bioinformatics in European Drug Discovery market: Revenue Forecasts (France), 2006-2013
• Opportunities for Bioinformatics in European Drug Discovery market: Revenue Forecasts (Scandinavia), 2006-2013
• Opportunities for Bioinformatics in European Drug Discovery market: Revenue Forecasts (Benelux), 2006-2013